Palatin Technologies (PTN) EPS (Basic) (2010 - 2026)
Palatin Technologies' (PTN) quarterly EPS (Basic) came in at -$0.37 in Q1 2026, up 95.97% on a YoY basis from -$0.19 in Q1 2025, and up 87.19% quarter-over-quarter from -$2.86 in Q4 2025.
Analysis
Palatin Technologies (PTN) EPS (Basic) (2010 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported EPS (Basic) for 17 consecutive years, with -$0.37 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 95.97% year-over-year to -$0.37; the trailing twelve-month figure through Mar 2026 stood at -$1.6 (up 96.38% YoY), and the FY2025 full-year result was -$32.85, down 1523.51% from the prior year.
- EPS (Basic) advanced to -$0.37 in Q1 2026 per PTN's latest filing, from -$2.86 in the prior quarter.
- Across five years, EPS (Basic) topped out at $4.81 in Q3 2025 and bottomed at -$9.08 in Q1 2025.
- Historically, EPS (Basic) has averaged -$0.87 across 5 years, with a median of -$0.37 in 2026.
- The widest YoY moves for EPS (Basic): up 1341.99% in 2025, down 2182.21% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.03 in 2022, then tumbled by 1900.32% to -$0.56 in 2023, then surged by 77.48% to -$0.13 in 2024, then sank by 2182.21% to -$2.86 in 2025, then soared by 87.19% to -$0.37 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.37, -$2.86, and $4.81 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | -0.37 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -2.86 |
| Sep 30, 2025 | 4.81 |
| Jun 30, 2025 | -4.26 |
| Mar 31, 2025 | -9.08 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -0.56 |
| Mar 31, 2024 | -0.60 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | -0.50 |
| Jun 30, 2023 | -0.04 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | -0.03 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.05 |
| Mar 31, 2022 | -0.03 |
| Dec 31, 2021 | -0.04 |
| Sep 30, 2021 | -0.03 |
| Jun 30, 2021 | 0.01 |